A new series of potent antagonists of excitatory neurotransmission in the rat hippocampus has been identified. These derivatives of piperazine-2,3-dicarboxylate (PzDA) include the most potent acidic amino acid antagonists yet described for Schaffer collateral-commissural EPSPs. These antagonists also effectively block excitatory synaptic responses recorded in the lateral and medial perforant pathways and in the mossy fiber pathway.
A new series of potent antagonists of excitatory neurotransmission in the rat hippocampus has been identified. These derivatives of piperazine-2,3-dicarboxylate (PzDA) include the most potent acidic amino acid antagonists yet described for Schaffer collateral-commissural EPSPs. These antagonists also effectively block excitatory synaptic responses recorded in the lateral and medial perforant pathways and in the mossy fiber pathway.
The PzDA derivatives also block focal depolarizations produced by kainate, quisqualate, and N-methyl-D-aspartate. N-methyl-D-aspartate responses are more susceptible to inhibition by PzDA derivatives, although the spectrum of antagonism of iv-methyl-D-aspartate and synaptic responses by PzDA derivatives is not parallel. However, the antagonism of kainate and quisqualate responses by PzDA derivatives shows the same rank order of potency as synaptic responses. These data indicate that synaptic receptors in the hippocampus have a pharmacologic profile similar to that of kainate or quisqualate receptors.
A great deal of evidence suggests that most excitatory CNS synapses use L-glutamate or L-aspartate as a transmitter (Fagg and Foster, 1983; Fonnum, 1984) . The postsynaptic receptors mediating responses to L-glutamate and other amino acid excitants have been differentiated on the basis of their sensitivity to different agonists. Thus, the major excitatory amino acid receptors have been classified as those selectively activated by N-methyl-D-aspartate (NMDA), kainate, or quisqualate McLennan, 1983; Watkins and Evans, 1981) . Excitatory amino acid receptors of the three major classes are present in discrete afferent fields throughout the CNS, although the role of many of these receptors in excitatory neurotransmission is not clear (Fagg and Foster, 1983; Fonnum, 1984; Watkins and Evans, 198 1; Monagban and Cotman, 1985) .
A specific synaptic function of NMDA receptors has been demonstrated in the spinal cord and cortex through the use of selective antagonists for this receptor class Watkins, 1982, 1983; Evans et al., 1979 Evans et al., , 1982 Thompson et al., 1985) . Extracellular recordings of other CNS excitatory pathways indicate that many monosynaptic responses are not susceptible to inhibition by specific NMDA antagonists, and, therefore, are mediated by a non-NMDA receptor type.
Precise pharmacological comparisons of synaptic and kainate or quisqualate receptors have not been possible because of the paucity ofantagonists for these receptors (Foster and Fagg, 1984; McLennan, 1983; Watkins and Evans, 198 1) . However, several derivatives of piperazine-2,3-dicarboxylate have recently been shown to be antagonists of monosynaptic afferent stimulation and kainate and quisqualate responses in several vertebrate spinal cord preparations (Davies et al., 1984) . We have tested these new antagonists with respect to antagonism of excitatory synaptic transmission and amino acid excitant responses in the rat hippocampus. Some of these data have been presented in abstract form .
Materials and Methods

Preparation of slices
Hippocampal slices were obtained from 45-60 d male Sprague-Dawley rats as described previously (Koemer and Cotman, 1982; White et al., 1979) . Following dissection and cutting, 450 pm slices were maintained in a static fluid bath containing experimental medium (124 mM NaCl, 3.3 mM KCl, 1.2 mM KH,PO,, 26.4 mM NaHCO,, 2.5 mM CaCl,, 2.4 mM MgSO,, and 10 mM D-glucose) at 32-34°C with their upper surfaces exposed to a warm, humid 95% O/5% CO, atmosphere. Following an equilibration period of l-l.5 hr, slices were transferred one at a time to a recording chamber (Koemer and Cotman, 1983 ) modified for continuous superfusion of medium. Slices were secured in the recording chamber with an upper net and submerged in continuously flowing (0.5-1 ml/min) medium. Antagonist solutions were applied by switching the superfusion fluid from control medium to medium containing specific concentrations of antagonist compounds.
Synaptic responses
Synaptic responses were elicited by electrical stimulation at 0.1 Hz from a twisted pair of 25 pm stainless steel wires. Stimulus intensity was adjusted to elicit synaptic field potentials just below threshold for eliciting a population spike. The stimulating electrode was placed in different regions for stimulating Schaffer collateral-commissural, mossy fiber, lateral perforant, or the medial perforant pathway (Lanthom and Cotman, 198 1; White et al., 1979) . Extracellular synaptic field potentials were recorded with a 4-10 MQ glass micropipette placed in the appropriate synaptic field.
Stimulating electrode placement was especially critical for mossy fiber responses; the stimulating electrode was placed just on the hilar side of the granule cell layer in the dentate gyrus. Field potentials in several locations along the CA3 pyramidal cell apical dendrites were examined for a given stimulating electrode placement. Mossy fiber responses were used only with a stimulating electrode placement that produced a prominent negativity in, but not distal to, stratum lucidum.
Lateral perforant path responses were obtained by positioning the stimulating and recording electrodes in the outer molecular layer of the dentate gyrus so as to record a response that exhibited potentiation in response to paired stimulation at 60 and 360 msec interstimulus intervals. Medial perforant path responses were obtained by placing the stimulating and recording electrodes in the middle molecular layer of the dentate gyrus so as to record a response that exhibited depression in response to paired stimulation at 60 and 360 msec interstimulus intervals (McNaughton, 1980) . Schaffer collateral-commissural syn-aptic field potentials were obtained by positioning the stimulating and recording electrodes in CA1 stratum radiatum.
Intracellular recordings
Intracellular recordings were from CA1 pyramidal neurons using 4 M potassium acetate electrodes with DC resistances of 40-80 MQ. A WPI M701 electrometer was equipped with a bridge circuit for passing current through the recording electrode. Recordings were from slices bathed in 10 PM picrotoxin-containing medium to depress the large inhibitory potentials recorded intracellularly in these neurons. Concentrations of Mg*+ and Ca*+ were raised to 4-6 mM in slices exposed to picrotoxin to suppress epileptiform activity induced by blocking inhibitory responses (Brown and Johnston, 1983) . Intracellular recordings were from neurons with resting potentials of at least -55 mV, input resistances of greater than 20 MQ, and action potential amplitudes greater than 80 mV.
Excitant amino acid responses
Extracellular focal potentials (Flatman and Lambert, 1979; Ganong and Cotman, 1982; Lanthom and Cotman, 1983) induced by iontophoretic application of excitatory amino acids were recorded with a glass micropipette placed within about 100 pm of the iontophoretic pipette in stratum radiatum of field CA1 . The relative position of the recording and iontophoretic electrodes was adjusted following the initial placement to maximize the slope and amplitude of the focal potential produced by a brief iontophoretic application of an excitatory compound. Excitatory compounds were applied with lo-100 nA negative iontophoretic current pulses of 2-5 set adjusted to elicit focal potentials of l-3 mV maximum amplitude. Backing currents up to 10 nA were used when necessary. Responses to iontophoretically applied excitatory compounds were measured from a continuous DC record on a chart recorder. Current pulses were applied 1 min apart to barrels of the iontophoretic pipette containing quisqualate, kainate, and NMDA, and there was a 2 min interval before the next successive applications of the agonists in that order. Excitant amino acid responses were recorded in the presence of 1 PM TTX. Antagonists were applied by switching the control medium in which the slice was submerged to antagonist solutions.
Compounds
Solutions of 20 mM quisqualate (Sigma), kainate (Sigma), and NMDA (Tocris Chemicals, Essex) were dissolved in 20 mM NaCl and adjusted to pH 7-8 with NaOH. Picrotoxin, TTX, and L-glutamate were obtained from Sigma. n,L-2-Amino-7-phosphonoheptanoate, the D-and L-isomers of 2-amino-5-phosphonopentanoate, and cis-2,3-piperidine dicarboxylate were obtained from Tocris. Piperazine-2,3-dicarboxylate (PzDA) derivatives were synthesized in the laboratory of J. C. Watkins, Bristol. The structures of these derivatives are shown in Figure 1 .
Results
Antagonism of Schafler responses by PzDA derivatives
Derivatives of PzDA applied as 10-1000 PM solutions were tested as antagonists of Schaffer collateral~ommissural synaptic responses. Synaptic field potentials recorded from submerged slices were rapidly and reversibly depressed in a dose-dependent fashion by solutions of these derivatives (Fig. 2) . The antagonism of Schaffer field potentials by PzDA analogs is summarized in Figure 3 .
There were significant differences in the abilities of various PzDA derivatives to depress Schaffer responses. Piperazine-2,3-dicarboxylate was a relatively poor antagonist of the Schaffer response; PzDA inhibited this response by 10 f 4% at 1000 PM (mean f SEM, n = 4). The N-benzoyl derivative of PzDA (BPzDA) was more effective than PzDA as a synaptic antagonist.
Application of 1000 FM B-PzDA inhibited Schaffer field potentials by 69 f 3% (n = 4), and 200 FM B-PzDA inhibited Schaffer responses by 34 f 2% (n = 4). Several chlorobenzoyl PzDA derivatives were also tested: N-( m-chlorobenzoyl)piperazine-2,3-dicarboxylate (m CB-PzDA) and N-( o-chlorobenzoyl)piperazine-2,3-dicarboxylate (OCRPzDA) were less potent than B-PzDA (Fig. 3 ). 
The most potent antagonists of Schaffer responses tested were N-(p-chlorobenzoyl)piperazine-2,3-dicarboxylate (pCB-PzDA) and N-(p-bromobenzoyl)piperazine-2,3-dicarboxylate (pBBPzDA). These antagonists applied at 200 I.IM depressed Schaffer responses by 5 1 f 5% (n = 6) and 48 f 2% (n = 4), respectively (Figs. 2, 3) . The Kds calculated for these compounds treated as simple competitive antagonists (Koerner and Cotman, 1982) were 203 PM for pCB-PzDA and 197 FM for pBB-PzDA. The Kd values calculated for these and the other PzDA derivatives against the Schaffer response were useful for comparing the relative potency of these compounds as synaptic antagonists. Kd values for the other PzDA derivatives were as follows: PzDA, 6700 PM; oCB-PzDA, 1660 PM; mCB-PzDA, 550 PM; and B-PzDA, 420 PM.
Antagonism of other hippocampal pathways
The two most potent Schaffer response antagonists, pCB-PzDA and pBB-PzDA, were also tested at concentrations from 10 to 1000 I.LM as antagonists in other excitatory hippocampal pathways. These two compounds exhibited similar effects on mossy fiber, lateral perforant path, and medial perforant path responses as on Schaffer synaptic field responses (Fig. 4) . Mossy fiber and perforant path responses were inhibited in the range of 50-80% by 200 FM solutions of pCB-PzDA and pBB-PzDA. The dose dependence of antagonism of mossy fiber and perforant path responses to these compounds is shown in Figure 5 ; these dose-response relationships can be compared to those for Schaffer responses shown in Figure 3 . The effects of pCB-PzDA and pBB-PzDA on the four different hippocampal excitatory pathways tested were similar in terms of the time course and reversibility of inhibition and the percent depression of these responses by 1 O-l 000 PM solutions of these antagonists. The slightly greater effect of pCB-PzDA and pBB-PzDA on mossy fiber responses compared to Schaffer and perforant path responses may have been due to partial contamination of the mossy fiber response by a population spike (Ault and Nadler, 1982) .
Antagonism of intracellularly recorded EPSPs
Intracellularly recorded EPSPs were antagonized by pBB-PzDA and pCB-PzDA. Figure 6A shows the inhibition of the Schaffer collateral-commissural EPSP by 1000 PM pBB-PzDA. Intracellularly recorded Schaffer EPSPs were antagonized 90 f 2% (n = 2) by 1000 PM pBB-PzDA and 48 f 5% ( PzDA PM pBB-PzDA. Schaffer EPSPs were also blocked by pCB-PzDA. This antagonist blocked the Schaffer EPSP by 88 + 6% (n = 3) at 1000 PM and by 5 5 f 4% (n = 3) at 200 PM. The inhibition of Schaffer EPSPs by these antagonists was similar to the inhibition of extracellularly recorded field potentials in terms of time course, reversibility, and potency (cf. Fig. 3A ). Subthreshold EPSPs elicited by low-intensity stimulation and suprathreshold EPSPs that reached firing threshold for action potentials were blocked equally by pBB-PzDA and pCB-PzDA.
Lack of antagonism of Schaffer EPSPs by NMDA antagonists In contrast to the antagonism by PzDA analogs of Schaffer synaptic responses, specific NMDA antagonists did not block Schaffer responses (Fig. 7) . Intracellularly recorded Schaffer EPSPs were blocked by less than 10% by 50 FM D-2-amino-5 phosphonopentanoate (~-Al's) or 100 FM D,L-2-amino-7-phosphonoheptanoate (DL-APT).
These specific concentrations of these antagonists block NMDA responses by over 90% without blocking kainate or quisqualate responses in the hippocampus (Hablitz and Langmoen, 1984; Harris et al., 1984) and other CNS structures Evans et al., 1982) . Subthreshold Schaffer EPSPs (mean amplitude, 2.2 _+ 0.3 mV, n = 6) were blocked 5 f 1 l%, and action potentials elicited by suprathreshold orthodromic stimulation were not blocked by 50 PM D-AP~ (Fig. 7A) . Similarly, subthreshold EPSPs (2.0 + 0.3 mV, n = 4) were blocked less than lo%, and EPSPs that reached firing threshold were not blocked by applications of 100 PM DL-AW (Fig. 7B) . Application of the L-isomer of AP5 to two CA1 neurons also blocked sub-and suprathreshold EPSPs less than 10%.
Lack of excitatory eflects
None of the PzDA derivatives we tested (Fig. 3) showed signs of excitatory activity toward hippocampal neurons. When applied as 1 O-l 000 PM solutions, these compounds depressed synaptic field potentials without exhibiting extracellular signs of agonist activity such as appearance of a population spike or an abnormally steep dose-response curve at higher drug concentrations (Koerner and Cotman, 1982) . In addition, we recorded extracellular DC potentials in CA1 stratum radiatum during applications of 10 mM droplets of several acidic amino acids, including the PzDA derivatives described above. Application of L-glutamate produced extracellular depolarizations of 2-6 mV (Lanthom and Cotman, 1983) . As described by others (Collingridge et al., 1983a; Crunelli et al., 1983; Koemer and Cotman, 1982) , cis-2,3-piperidine dicarboxylate produced excitatory responses with focal depolarizations up to 10 mV and also elicited epileptiform-like bursting activity in some slices. The PzDA derivatives listed in Figure 1 , applied as 10 mM droplets, did not elicit excitatory responses in the form of DC depolarizations or neuronal firing. The largest focal depolarizations elicited by PzDA derivatives were less than 0.5 mV. A more direct examination of nonspecific effects of PzDA derivatives was made during intracellular recordings from CA1 pyramidal neurons. Application of 200 and 1000 PM pCB-PzDA and pBB-PzDA never affected resting membrane potential, action potential amplitude, or input resistance in the eight CA1 pyramidal neurons to which these antagonists were applied (Fig.  6B) .
Antagonism of excitant amino acid responses
The ability of PzDA derivatives to antagonize responses produced by amino acid excitants was examined by applying quisqualate, kainate, and NMDA to CA1 stratum radiatum using multibarrel iontophoretic pipettes. The effects of applications of 1000 I.LM solutions of PzDA derivatives on extracellular focal depolarizations produced by these excitants are shown in Figure  8 Each of the PzDA derivatives we tested depressed NMDA responses to a greater extent than kainate or quisqualate responses. Several of these derivatives-including PzDA, mCB-PzDA, and pCB-PzDA-were quite potent as NMDA blockers; these antagonists blocked NMDA focal depolarizations by 80-90% (Fig.   9 ).
The order of potency of the PzDA derivatives shown in Figure  9 against kainate responses exactly matches their order of potency against Schaffer synaptic responses, although the PzDA derivatives were less potent against kainate-induced responses compared to Schaffer synaptic responses, with the exception of PzDA. Depression of kainate responses by 1000 PM antagonist solutions ranged from 23 -t 3% (n = 4) for PzDA to 66 f 6% (n = 4) for pCB-PzDA.
The inhibition by PzDA derivatives of quisqualate responses was similar to that of kainate and the Schaffer synaptic response, although quisqualate-induced responses were depressed less by PzDA derivatives than NMDA or kainate responses (Fig. 9) . Inhibition of quisqualate responses by 1000 PM antagonist solutions ranged from 5 to 30%.
Discussion
The PzDA derivatives, particularly pCB-PzDA and pBB-PzDA, must be considered as important new antagonists of excitatory these compounds are significantly more potent than previously available amino acid antagonists such as kynurenate, y-D-glutamylglycine, and cis-2,3-piperidine dicarboxylate (ColI&ridge et al., 1983b; Ganong et al., 1983b; Koemer and Cotman, 1982; Robinson et al., 1984) . The depressant action of this series of compounds against the Schaffer synaptic response Figure 7 . Specific NMDA antagonists do not inhibit Schaffer collateral-commissural EPSPs. Three different stimulus intensities were used to produce two subthreshold and one suprathreshold intracellularly recorded Schaffer EPSP. A, Schaffer EPSPs in 50 PM D-AP~ compared to control medium. B, Schaffer EPSPs in 100 PM DL-AP~ compared to control medium. Waveforms are averages of three to six responses. Action potentials in suprathreshold responses are truncated. Submerged slices were exposed to antagonist solutions for at least 10 mm. The medium contained 10 ELM picrotoxin and elevated Ca*+ and Mg2+ (see Materials and Methods).
is similar to the inhibition of dorsal root monosynaptic excitation in the spinal cord (Davies et al., 1984) . Thus, pCB-PzDA and pBB-PzDA are the most potent synaptic antagonists of this series against hippocampal and spinal cord monosynaptic responses, while mCB-PzDA, oCB-PzDA, and PzDA are, in descending order, less potent. 
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The mechanism of action of these compounds is likely to be antagonism of the postsynaptic receptors that mediate synaptic transmission. Although we did not test effects on amino acid uptake or presynaptic release, the ability of PzDA analogs to block excitant amino acid-induced responses indicates that these antagonists act on postsynaptic receptors. Consistent with this notion is the observation that pCB-PzDA interacts with pairedpulse stimulation of the medial perforant path in a manner expected of a postsynaptic antagonist (Harris and Cotman, 1985) . In addition, pBB-PzDA causes a reduction in amplitude of spontaneous miniature EPSPs at the guinea pig mossy fiber-CA3 pyramidal neuron synapse, indicative of a postsynaptic action without showing nonspecific membrane effects (Ganong et al., 1985) . The PzDA series of analogs do not show the depolarizing actions toward hippocampal neurons that have been described for cis-2,3-piperidine dicarboxylate.
The major postsynaptic receptor type that mediates excitatory neurotransmission in the Schaffer pathway is not of the NMDA class. The lack of effect of the specific NMDA antagonists D-APL! and DL-APT on intracellularly recorded Schaffer EPSPs (Fig. 7) confirms observations from extracellular recording in this pathway (Collingridge et al., 1983b; Harris et al., 1984; Koemer and Cotman, 1982) . However, NMDA receptors may play a role in some aspect of synaptic transmission in this pathway, since Schaffer responses are affected by NMDA antagonists under certain conditions (Coan and Collingridge, 1985; Hablitz and Langmoen, 1984) , and long-term potentiation of the Schaffer synaptic response is blocked by NMDA antagonists (Collingridge et al., 1983b , Harris et al., 1984 Wigstrom and Gustafson, 1984) .
In addition to their effect on Schaffer responses, pCB-PzDA and pBB-PzDA antagonize excitatory synaptic responses in the medial and lateral perforant path and the mossy fiber path. Excitatory responses in these pathways were inhibited in the range of 50-80% by 200 PM solutions of these antagonists. The ability of these antagonists to block synaptic transmission in these pathways indicates the presence of a similar or identical postsynaptic receptor in these different pathways. In accordance with this view are the observations that there are similarities in the abilities of other acidic amino acid antagonists to depress the different hippocampal pathways (Collingridge et al., 1983b; Ciunelli et al., 1982 Ciunelli et al., , 1983 Ganong et al., 1983a, b; Koemer and Cotman, 1982; Lanthom et al., 1984; Robinson et al., 1983) . However, the lateral perforant path may have an additional receptor present, since L-2-amino-4-phosphonobutyrate is a potent antagonist of this pathway but not of the Schaffer collateralcommissural pathway (Collingridge et al., 1983b , Koemer and Cotman, 1981 ). Harris et al. (1984) . Each point represents the mean data from at least four slices. SEMs ranged from + 1 to &6%. Excitatory amino acid responses were recorded from slices submerged in medium containing 1 PM TTX. For abbreviations of compounds, see Figure 1 .
The PzDA derivatives we tested were more potent against NMDA-induced responses than kainate or quisqualate-induced responses in the hippocampus. The order of potency of PzDA derivatives against NMDA, kainate, and quisqualate responses is similar to the effects of r-D-glutamylglycine (Collingridge et al., 1983a; Crunelli et al., 1983; Davies and Watkins, 1983; Watkins et al., 198 1) and kynurenate (Cochran, 1983; Ganong et al., 1983a, b; Perkins and Stone, 1984) . These antagonists are also more potent against NMDA responses than against kainate or quisqualate responses and block hippocampal excitatory transmission (Collingridge et al., 1983b; Ganong et al., 1983b; Koemer and Cotman, 1982; Perkins and Stone, 1984; Robinson et al., 1983) . Amino acid-induced excitations in the spinal cord are also depressed by PzDA analogs, but in this region, quisqualate and kainate responses are more sensitive than NMDA responses to depression by PzDA derivatives (Davies et al., 1984) . The greater potency of PzDA derivatives against NMDA responses in the hippocampus may be due to differences in Mg2+ concentration used in the present study compared to the study of Davies et al. (1984) . NMDA-induced responses in neurons from several CNS structures are sensitive to changes in Mg2+ concentration (Ault et al., 1980; Crunelli and Mayer, 1984; Dingledine, 1983; Nowak et al., 1984) . The difference in relative potency of the PzDA analogs against NMDA and kainate or quisqualate in the spinal cord compared to hippocampus could also be due to the existence of NMDA receptor subtypes in these regions (McL.ennan, 1984; Perkins and Stone, 1983) .
The antagonism of Schaffer synaptic responses by PzDA derivatives closely resembles the antagonism of kainate responses by these compounds. The antagonism of quisqualate responses by PzDA derivatives shows a similar rank order of potency as kainate responses, although quisqualate responses are less sensitive to these antagonists. The similar rank order of potency of the PzDA series against kainate and quisqualate responses (Fig. 9) is probably due to the similarities in these receptor types, as shown by their interaction with a variety of ligands (Foster and Fagg, 1984) . The greater potency of hippocampal synaptic antagonists toward kainate, rather than quisqualate, receptors may indicate that synaptic receptors are more similar to the kainate type. Kainate binding sites have been shown to be enriched in synaptic junction membranes (Foster et al., 1981) although it is unlikely that kainate receptors are restricted to a synaptic location, since extrasynaptic kainate receptors have been demonstrated in the hippocampus (Fagni et al., 1983) and spinal cord (Davies et al., 1979) . The range of potencies of this new series of antagonists will be useful for further structureactivity analyses of ligands for synaptic receptors.
The relative potencies of derivatives of PzDA against synaptic and amino acid-induced excitations support a role for kainate (or quisqualate) postsynaptic receptors in excitatory neurotransmission in the hippocampus. The endogenous ligand for synaptic receptors remains unknown, although a great deal of biochemical evidence suggests that L-glutamate is a hippocampal excitatory transmitter (Cotman and Nadler, 1981; Fagg and Foster, 1983; Fonnum, 1984; Storm-Mathisen, 1977) . The high affinity of L-glutamate toward kainate and quisqualate receptors (Foster and Fagg, 1984; McLennan, 1983; Watkins and Evans, 198 1) is consistent with the notion that one of these receptor types could mediate postsynaptic actions of naturally released L-glutamate in the hippocampus.
